European Parliament Convenes to Address Type 1 Diabetes Research and Treatment Gaps

This past week, Breakthrough T1D helped organize an event in the European Parliament titled "Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes." Hosted by Member of European Parliament Tomislav Sokol, Ph.D., the meeting brought together patient advocates, researchers, and policymakers to discuss the urgent need for accelerated development and approval of breakthrough therapies across the EU.

Conversations between Breakthrough T1D representatives and European policymakers centered on the specific barriers and opportunities that exist in the EU regulatory and research environments. Two areas of particular focus were cell therapies and disease-modifying therapies—approaches that could meaningfully change outcomes for people living with Type 1 diabetes.

According to Campbell Hutton, Senior Vice President of Global Advocacy at Breakthrough T1D, the event represented an important step: "This event in the EU Parliament allows us to engage with important decision-makers to ensure that the research and policy environments are oriented in a way to accelerate development of T1D breakthrough therapies in the EU as we also do in other countries."

The meeting marked the beginning of an open dialogue between Breakthrough T1D and EU institutions, aimed at coordinating efforts to accelerate Type 1 diabetes breakthroughs and get new treatments to patients more quickly.

Origin: breakthrought1d.org (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.